natalizumab

Ligand id: 6591

Name: natalizumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: natalizumab

References
1. L├ęger OJ, Yednock TA, Tanner L, Horner HC, Hines DK, Keen S, Saldanha J, Jones ST, Fritz LC, Bendig MM. (1997)
Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
Hum Antibodies8 (1): 3-16. [PMID:9265500]
2. Mackay CR. (2008)
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
Nat. Immunol.9 (9): 988-98. [PMID:18711436]
3. No authors listed. (2004)
Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.
Drugs R D5 (2): 102-7. [PMID:15293871]